Name | N-{2-[2-(2-{3-[(2,5-Dioxo-1-pyrrolidinyl)oxy]-3-oxopropoxy}ethoxy)ethoxy]ethyl}-5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanamide |
---|---|
Synonyms |
MFCD11974977
N-{2-[2-(2-{3-[(2,5-Dioxo-1-pyrrolidinyl)oxy]-3-oxopropoxy}ethoxy)ethoxy]ethyl}-5-[(3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]pentanamide 1H-Thieno[3,4-d]imidazole-4-pentanamide, N-[2-[2-[2-[3-[(2,5-dioxo-1-pyrrolidinyl)oxy]-3-oxopropoxy]ethoxy]ethoxy]ethyl]hexahydro-2-oxo-, (3aS,4S,6aR)- |
Description | Biotin-PEG3-NHS ester is a PEG-based PROTAC linker can be used in the synthesis of PROTAC. |
---|---|
Related Catalog | |
Target |
PEGs |
In Vitro | PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins. |
Density | 1.4±0.1 g/cm3 |
---|---|
Molecular Formula | C23H36N4O9S |
Molecular Weight | 544.618 |
Exact Mass | 544.220276 |
LogP | -2.93 |
Index of Refraction | 1.574 |